Radiation oncology firm Elekta has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Versa HD radiation therapy system.
Versa HD offers beam shaping and tumor targeting, and can deliver radiation doses three times faster than previous Elekta linear accelerators, according to the vendor. Integrated with Elekta' Agility 160-leaf multileaf collimator, Versa HD can provide high-definition, high-speed beam shaping over a 40 x 40-cm field, the company said. A new high dose-rate mode also is included.
